RE: MR 10%10 Sep 2025 17:12
According to ChatGPT holders of most AIM shares do not have to disclose their positions at all when passing typical thresholds like 3% unless asked to by the company or by his own accord (voluntary), so that explains why he's only notified now...
"For AIM companies like Genedrive, there’s no automatic FCA TR-1 duty on holders. Instead, AIM Rule 17 puts the duty on the company to announce changes when it becomes aware of them; AIM suggests non-DTR issuers put DTR-style notify rules in their Articles, but it’s not automatic.
London Stock Exchange Docs
What forces a holder to tell the company?
The company’s Articles (if they include notify-at-3% rules).
A Companies Act s.793 disclosure notice from the company (compulsory).
Genedrive’s published Articles don’t contain DTR-style thresholds; they rely on s.793 powers to compel disclosure. So there isn’t a standing “you must notify at 3%, every 1%” rule baked into their Articles.
Genedrive
So why did you see a TR-1 today?
Because holders often volunteer a DTR-style notice (using the TR-1 template) and the issuer then RNS’s it under AIM Rule 17. Today’s RNS shows Nugent (SW) Ltd crossing 4.46% on 29 Jul 2025, notified 8 Sep 2025, published 10 Sep 2025—illustrating that notifications can be voluntary and lagged.
London South East
Bottom line:
Private investors in Genedrive are not automatically required by FCA rules to notify on threshold crossings. They must notify if the Articles require it (Genedrive’s don’t) or if asked via s.793. Otherwise, disclosures happen when investors volunteer info and the company then announces it under AIM Rule 17."